Maitreya Medicare (NSE:MAITREYA) Short-Term Debt: ₹11.79 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MAITREYA Maitreya Medicare Ltd NSE:MAITREYA
26 GF Score
Price ₹116.00
GF Value ₹459.95
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Maitreya Medicare Short-Term Debt?

Maitreya Medicare NSE:MAITREYA -4.13% 26 Short-Term Debt is ₹11.79 Mil as of Mar. 2026. GuruFocus rates NSE:MAITREYA with a GF Score™ of 26/100 and a GF Value™ of ₹459.95 (Possible Value Trap). The stock has 7 warning signs investors should review.

Maitreya Medicare's Short-Term Debt for the quarter that ended in Mar. 2026 was ₹11.79 Mil.

Maitreya Medicare's quarterly Short-Term Debt increased from Mar. 2025 (₹0.00 Mil) to Sep. 2025 (₹14.63 Mil) but then declined from Sep. 2025 (₹14.63 Mil) to Mar. 2026 (₹11.79 Mil).

Maitreya Medicare's annual Short-Term Debt declined from Mar. 2023 (₹12.87 Mil) to Mar. 2025 (₹0.00 Mil) but then increased from Mar. 2025 (₹0.00 Mil) to Mar. 2026 (₹11.79 Mil).

Maitreya Medicare Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Maitreya Medicare Short-Term Debt Related Terms

Maitreya Medicare Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Maitreya Medicare's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Maitreya Medicare Short-Term Debt Chart

Maitreya Medicare Annual Data
Trend Mar21 Mar22 Mar23 Mar25 Mar26
Short-Term Debt
11.87 12.40 12.87 0.00 11.79

Maitreya Medicare Semi-Annual Data
Mar21 Mar22 Mar23 Sep23 Sep24 Mar25 Sep25 Mar26
Short-Term Debt Get a 7-Day Free Trial 12.86 0.00 0.00 14.63 11.79
NSE:MAITREYA
26GF Score
Maitreya Medicare Ltd NSE:MAITREYA
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of ₹11.79 Mil mean?
Maitreya Medicare (NSE:MAITREYA) has a Short-Term Debt of ₹11.79 Mil as of Mar. 2026.
Is Maitreya Medicare's Short-Term Debt too high?
Maitreya Medicare's current Short-Term Debt is ₹11.79 Mil. Overall, Maitreya Medicare has a GF Score™ of 26/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maitreya Medicare's Short-Term Debt compare to HCA and DVA?
Maitreya Medicare's Short-Term Debt of ₹11.79 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Maitreya Medicare's current Short-Term Debt is ₹11.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maitreya Medicare stock overvalued right now?
Based on GuruFocus' analysis, Maitreya Medicare (NSE:MAITREYA) is currently considered Possible Value Trap. The stock's GF Value™ is ₹459.95, compared to a current price of ₹116.00 — trading 74.8% below its estimated fair value. The current Short-Term Debt is ₹11.79 Mil. Maitreya Medicare's overall GF Score™ is 26/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Maitreya Medicare (NSE:MAITREYA), the current Short-Term Debt is ₹11.79 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Maitreya Medicare (NSE:MAITREYA) Overvalued in 2026?

Based on GuruFocus' analysis, Maitreya Medicare stock appears to be undervalued. The current stock price of ₹116.00 is trading 74.8% below its estimated GF Value™ of ₹459.95. GuruFocus considers Maitreya Medicare to be Possible Value Trap.

Key valuation signals for NSE:MAITREYA:

  • Short-Term Debt: ₹11.79 Mil
  • GF Value™: ₹459.95 vs. price of ₹116.00 (74.8% below fair value)
  • GF Score™: 26/100 with 7 warning signs

No single metric tells the full story. See the NSE:MAITREYA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maitreya Medicare Business Description

Address Nr. Someshwara Char Rasta, Udhana - Magdalla Road, Surat, GJ, IND, 395007
Maitreya Medicare Ltd is Multi Superspeciality hospital. It is a 125 bedded hospital that provides multi-disciplinary integrated healthcare services, with a focus on primary secondary & tertiary care, and also offers a comprehensive range of healthcare services across over 18 specialties and super specialties, including Cardiology, Urology, Oncology, Laparoscopic Surgery, Neurology, Neurosurgery, Spine Surgery, Nephrology including Dialysis, Gastroenterology, Gastrointestinal surgery, Cardiothoracic Surgery, Oncosurgery, Orthopedic Surgery including joint replacements and Arthroscopic surgeries, Gynecology & High-Risk Obstetrics, Hepatocellular Billary Surgery, Critical Care Medicine etc.
26GF Score

Get the complete analysis for NSE:MAITREYA

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹116.00
Price
₹459.95
GF Value